CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
Sara Serra(Italian institute for Genomic Medicine), Silvia Deaglio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Fabio Malavasi(Fondazione Ricerca Molinette), Alberto L. Horenstein(Fondazione Ricerca Molinette), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Tiziana Vaisitti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Luca Laurenti(Sapienza University of Rome), Marta Coscia(University of Turin), Simon C. Robson(Beth Israel Deaconess Medical Center), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Davide Brusa(Italian institute for Genomic Medicine), Giovanni D’Arena(University of Modena and Reggio Emilia), Claudio Tripodo(University of Palermo), Giorgio Inghirami(NewYork–Presbyterian Hospital)
Cited by 138
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901